PRESS RELEASES
Date, October 4, 2024
CAMK2 Therapeutics Network Awarded Chan Zuckerberg Initiative Rare As One Grant
CAMK2 Therapeutics Network is excited to announce that it has been awarded the prestigious Rare As One Grant from the Chan Zuckerberg Initiative.
This significant grant will support its mission to build capacity within its patient-led rare disease organization and drive forward critical collaborative scientific research.
The grant commences on October 1, 2024, and extends through September 30, 2029.
Date, November 6, 2023
Contact: Bonnie Dwyer, CAMK2 Executive Director, dwyerbk@gmail.com